TETRA Technologies, Inc. (TTI) News
Track canonical SquawkNews coverage tagged to TTI, TETRA Technologies, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Thiogenesis reports 2026 annual and special meeting results
Thiogenesis Therapeutics announced results of its 2026 annual and special meeting of shareholders and provided a corporate update.
EQUITY | Sep 21, 2026, 08:01 AM UTC
L
Thiogenesis hires Brisco Capital for investor relations
Thiogenesis Therapeutics said it has engaged Brisco Capital for investor relations. The company is a clinical-stage biotech developing sulfur-based therapeutics for rare diseases.
EQUITY | Sep 03, 2026, 10:06 AM UTC
L
TTI - TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
TTI - TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
EQUITY | Sep 02, 2026, 05:49 PM UTC
L
TTI - TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
TTI - TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
EQUITY | Aug 03, 2026, 09:58 PM UTC
L
Tetra Technologies Insider Sold Shares Worth $536,745, According to a Recent SEC Filing
() -- Brady M Murphy, President & CEO, on July 01, 2026, sold 50,061 shares in Tetra Technologies (TTI) for $536,745. Following the Form 4 filing with the SEC, Murphy has control over a total of 2,965,396 common shares o
GEOPOLITICS | Jul 02, 2026, 09:07 PM UTC
L
Northland Capital Markets Maintains Outperform on Tetra Technologies, Raises Price Target to $14
Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE: TTI ) with a Outperform and raises the price target from $11.5 to $14.
EQUITY | Jun 30, 2026, 05:04 PM UTC